Monday, August 31, 2026

Peloton Stock Went Up By Over 11% So Far On Tuesday

ViaNews Editorial Team

December 22, 2020

Peloton Stock Went Up By Over 11% So Far On Tuesday

Shares of Peloton rose by a staggering 11.87% to $161.52 at 11:14 EST on Tuesday, after five consecutive sessions in a row of gains. The Nasdaq Stock Market is rising 0.46% to $12,800.90, after two consecutive sessions in a row of losses. This seems, up to now, a somewhat positive trend trading session today.

Peloton's last close was $144.39, 2.92% below its 52-week high of $166.23.

News about Peloton today

Stocks making the biggest moves in the premarket: Peloton, sportsman's warehouse, fubotv & more. According to today's article on CNBC, "Peloton (PTON) - Peloton is acquiring rival fitness equipment maker Precor for $420 million, in a deal that will give it more market share as well as increased manufacturing capacity. ", "The acquisition prompted KeyBanc Capital Markets to raise its price target on Peloton from $160 to a Street-high $185, saying the deal was "highly synergistic" and supportive of long-term growth. "

The company's growth estimates for the ongoing quarter and the next is 140% and 115%, respectively.

Peloton's Revenue

Year-on-year quarterly revenue growth grew by 232.4%, now sitting on 2.36B for the twelve trailing months.

Peloton's Stock Yearly Top and Bottom Value

Peloton's stock is valued at $161.52 at 11:14 EST, under its 52-week high of $166.23 and way higher than its 52-week low of $17.70.

Peloton's Moving Average

Peloton's value is way higher than its 50-day moving average of $115.23 and way higher than its 200-day moving average of $88.73.

Previous days news about Peloton

Peloton makes biggest purchase with $420 million precor deal. According to Bloomberg Quint on Mon Dec 21, "Through the deal, Peloton will gain 625,000 square feet (58,000 square meters) of manufacturing capacity in Whitsett, North Carolina, and Woodinville, Washington. ", "Peloton sales have soared this year as the pandemic shut gyms and forced people to work out from home. "

Peloton to buy fitness equipment maker precor in $420 million deal. According to MarketWatch on Mon Dec 21, "S.consumers, Peloton will be able to deliver connected fitness products to members sooner," the company stated in its news release.", "The companies expect the deal to close early in the new year, and Peloton projects that it will produce equipment manufactured in the U.S. by the end of the year. "

Peloton will spend $420 million to acquire precor, known for making fitness equipment found in hotels, health clubs, and university gyms. According to Business Insider on Mon Dec 21, ""By combining our talented and committed R&D and Supply Chain teams with the incredibly capable Precor team and their decades of experience, we believe we will be able to lead the global connected fitness market in both innovation and scale," Peloton president William Lynch said in a release.", "The deal is Peloton's largest to date, according to Bloomberg."

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com